H3827
Resolutions urging the Congress of the United States to update the Drug Addiction Treatment Act of 2000 and remove excessive training requirements mandated for obtaining a waiver to prescribe buprenorphine
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To Governor
- Became Law
Bill overview
This resolution urges the U.S. Congress to revise the Drug Addiction Treatment Act of 2000 and reduce the extensive training requirements needed for physicians to receive waivers allowing them to prescribe buprenorphine, a medication used to treat opioid addiction. Currently, these requirements are seen as barriers to access for qualified healthcare providers. The resolution aims to increase the availability of this vital medication for individuals struggling with substance use disorders. It is a legislative effort to streamline the process for prescribing buprenorphine.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Bruce J. Ayers
Cosponsor
Bruce J. Ayers
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.